Ginkgo Bioworks Holdings (DNA) Total Liabilities (2019 - 2026)

Ginkgo Bioworks Holdings has reported Total Liabilities for 8 years, with the latest figure at $589.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 8.69% year-over-year to $589.9 million; the trailing twelve-month figure through Mar 2026 stood at $589.9 million (down 8.69% YoY), and the FY2025 full-year result was $611.1 million, down 7.6% from the prior year.
• Total Liabilities for Q1 2026 stood at $589.9 million, down from $611.1 million in the prior quarter.
• The five-year high for Total Liabilities was $809.6 million in Q1 2023, with the low at $427.2 million in Q2 2022.
• Historically, Total Liabilities has averaged $639.4 million across 5 years, with a median of $629.4 million in 2025.
• Annual changes were most pronounced in 2022 — Total Liabilities soared 195.51% — and 2023, when it decreased 29.25%.
• Ginkgo Bioworks Holdings' Total Liabilities stood at $803.0 million in 2022, then declined by 29.25% to $568.2 million in 2023, then advanced by 16.4% to $661.4 million in 2024, then retreated by 7.6% to $611.1 million in 2025, then fell by 3.47% to $589.9 million in 2026.
• The last three Total Liabilities figures came in at $589.9 million (Q1 2026), $611.1 million (Q4 2025), and $629.4 million (Q3 2025), per Business Quant data.